Reduction of Nightmares and Other PTSD Symptoms in Combat Veterans by Prazosin: A Placebo-Controlled Study

The development of a Clinician-Administered PTSD Scale

1995 • 4,445 citations

Physicians Desk Reference

1994 • 2,653 citations

Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder

1997 • 709 citations

CSF Norepinephrine Concentrations in Posttraumatic Stress Disorder

2001 • 451 citations

α-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function

1999 • 240 citations

The α1-Adrenergic Antagonist Prazosin Improves Sleep and Nightmares in Civilian Trauma Posttraumatic Stress Disorder

2002 • 156 citations

The alpha1-Adrenergic Antagonist Prazosin Ameliorates Combat Trauma Nightmares in Veterans With Posttraumatic Stress Disorder

2000 • 152 citations

Prazosin Reduces Nightmares in Combat Veterans With Posttraumatic Stress Disorder

2002 • 144 citations

Laboratory sleep correlates of nightmare complaint in PTSD inpatients11The percentage of nights with nightmare reports across these four studies could rise to 41% if indeterminate numbers of nightmares and nights observed were set to their respective upper and lower bounds.

2000 • 139 citations

THE USE OFα-ADRENOCEPTOR ANTAGONISTS IN THE PHARMACOLOGICAL MANAGEMENT OF BENIGN PROSTATIC HYPERTROPHY: AN OVERVIEW

1996 • 77 citations

Cerebrospinal Fluid Corticotropin-Releasing Hormone in Healthy Humans: Effects of Yohimbine and Naloxone

2000 • 52 citations

Sleep suppression induced by intravenous and intraventricular infusions of methoxamine in the dog

1977 • 40 citations

Current status of pharmacotherapy for PTSD: An effect size analysis of controlled studies

1996 • 33 citations

Cerebrospinal Fluid Corticotropin-Releasing Hormone in Healthy Humans: Effects of Yohimbine and Naloxone¹

2000 • 6 citations

Current status of pharmacotherapy for PTSD: An effect size analysis of controlled studies

1996 • 2 citations